| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |